
1. Technology overview
Astraea is a Y Combinator Spring 2026 company; its site lists Mountain View, California and the legal notice Omni Strategies Inc. It sells AI software to clinical trial sponsors and their biometrics teams, aimed at the manual conversion of raw trial data into regulatory submission outputs.
From a protocol and raw study data, the platform generates SDTM and ADaM datasets, TFL shells, statistical code in R and SAS, edit checks and visualizations, with Pinnacle 21 checks and variable-level traceability. Forward-deployed engineers install it in the sponsor's environment, and qualified experts review and approve every output.
2. Highlighted features & specifications
- Data management: generates edit checks from the protocol and flags discrepancies for review.
- Data analysis: produces SDTM and ADaM datasets, R and SAS code and populated TFLs.
- Data visualization: builds clinical charts such as Kaplan-Meier curves from plain-language prompts.
- Standards automation: SDTM mapping, ADaM derivations and Pinnacle 21 checks.
- Traceability and QC: variable-level traceability and review gates before regulatory formatting.
- Forward-deployed setup: engineers install and configure it inside the customer environment.
3. Potential application
Pharma and biotech sponsors could automate SDTM and ADaM preparation for oncology or rare disease studies. CROs in the region could speed up statistical programming for global trials. Biometrics teams could add automated QC before regulatory submission.
4. Benefits
The site cites SDTM, ADaM and TFL delivery in 2 days instead of months. Outputs are traceable at variable level from source data to TFL. Software runs in the sponsor's own environment alongside existing CRO or in-house teams. Experts review and approve every output.
5. Market trends & opportunities
Clinical trial programs generate more complex data while biometrics work still depends on large teams of statistical programmers and CRO services. Sponsors seek ways to cut submission timelines. Vietnamese and ASEAN CROs and pharma partners running global trials face the same CDISC workload.
6. Other information
Y Combinator Spring 2026 batch. Site footer: Mountain View, California, 2026 Omni Strategies Inc. Sponsor of the BBSW 2026 conference (Gold). Founding year not stated.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































